DACT1 and osteosarcoma: Interestingly, IGF2BP1 fails to stabilize DACT1 after the m6A modification is eliminated by FTO, leading to the downregulation of DACT1 and further stimulation of the Wnt/β-catenin pathway in osteosarcoma 35.